Novavax, Inc. (NASDAQ:NVAX)’s shares jumped 4.34% to $6.01. The company announced that it will host a conference call and webcast to report its fourth quarter and year-end 2013 financial results on Monday, March 10, 2014, at 4:30 p.m. ET. Novavax, Inc. (NASDAQ:NVAX) stock opened at $6.17 in last session, and closed at $6.65, while the day range of stock is $6.17 -$6.92. The stock showed a positive weekly performance of 15.25%.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), announced on Tuesday that the U.S. Food and Drug Administration accepted its new drug application for intravenous influenza treatment peramivir for review. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stock opened at $11.81, in last session and closed at $12.01, by gaining 1.26%. The 52 week range of the stock is $1.12 -$13.33. Company’s market capitalization is $709.69 million.
Trade-Ideas LLC identified Anika Therapeutics Inc. (NASDAQ:ANIK) as a “perilous reversal” (up big yesterday but down big today) candidate. Anika Therapeutics, Inc. (NASDAQ:ANIK) stock decreased -4.73% and finished the last session at $43.73. The EPS of the stock remained 1.26. Company’s market capitalization is $604.59 million.
Agenus Inc. (NASDAQ:AGEN) will release its fourth quarter and year end 2013 financial results before the market opens on March 5, 2014. Agenus Inc (NASDAQ:AGEN) stock opened the session at $5.04, and closed the session at $4.89. The 52 week range of the stock remained $2.40 – $5.40 and the day range was $4.79 – $5.27.